Sphingolipids from the human fungal pathogen Aspergillus fumigatus. - Institut Pasteur Access content directly
Journal Articles Biochimie Year : 2017

Sphingolipids from the human fungal pathogen Aspergillus fumigatus.

Thierry Fontaine


Sphingolipids (SPLs) are key components of the plasma membrane in yeast and filamentous fungi. These molecules are involved in a number of cellular processes, and particularly, SGLs are essential components of the highly polarized fungal growth where they are required for the formation of the polarisome organization at the hyphal apex. Aspergillus fumigatus, a human fungal pathogen, produce SGLs that are discriminated into neutral cerebrosides, glycosylinositolphosphoceramides (GIPCs) and glycosylphosphatidylinositol (GPI) anchors. In addition to complex hydrophilic head groups of GIPCs, A. fumigatus is, to date, the sole fungus that produces a GPI-anchored polysaccharide. These SPLs follow three different biosynthetic pathways. Genetics blockage leading to the inhibition of any SPL biosynthesis or to the alteration of the structure of SPL induces growth and virulence defects. The complete lipid moiety of SPLs is essential for the lipid microdomain organization and their biosynthetic pathways are potential antifungal targets but remains understudied.


Fichier principal
Vignette du fichier
1-s2.0-S0300908417301591-main.pdf (1.33 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

pasteur-01580433 , version 1 (01-09-2017)


Attribution - NonCommercial - ShareAlike



Thierry Fontaine. Sphingolipids from the human fungal pathogen Aspergillus fumigatus.. Biochimie, 2017, ⟨10.1016/j.biochi.2017.06.012⟩. ⟨pasteur-01580433⟩


272 View
595 Download



Gmail Facebook Twitter LinkedIn More